SenzaGen receives SEK 0.65 million order for in vitro skin allergy and irritation tests from global consumer product company

SenzaGen continues to receive orders from large global companies. A leading consumer product company has now entrusted SenzaGen to test product candidates during their product development phase. Valued at SEK 0.65 million, the project includes non-animal tests for both skin sensitization and skin irritation.

SenzaGen has started to collaborate with a global consumer product company with operations in several business areas and product groups. The company aims to use the combination of tests to evaluate whether product candidates may cause skin sensitization or irritation. Since July 1, 2021, SenzaGen’s expanded service offerings include in vitro tests for skin irritation and corrosion, as a complement to the innovative GARD® platform with tests for skin and respiratory sensitization.

“It is promising that we already get orders for our new endpoint skin irritation. The order confirms the feedback we have received from customers, and our strategy to broaden our testing services by offering customers in our priority markets a wider range of tests within non-animal skin toxicology, in this case both skin sensitization and skin irritation", says Axel Sjöblad, CEO of SenzaGen.

Demand for contract research services for non-animal skin toxicological testing is continuously growing in SenzaGen’s target markets, where the company is well positioned. The testing and assessment of toxicity and potential risk of chemicals, drug candidates, and medical devices is a requirement for regulatory filings.